HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yan Wang Selected Research

xuesetong

1/2024Correction for: Xuesaitong promotes myocardial angiogenesis in myocardial infarction mice by inhibiting MiR-3158-3p targeting Nur77.
1/2023Xuesaitong promotes myocardial angiogenesis in myocardial infarction mice by inhibiting MiR-3158-3p targeting Nur77.
9/2021Xuesaitong injection treating acute myocardial infarction: A systematic review and meta-analysis.
11/2018[Retrospective analysis and discussion on 74 cases of adverse reactions of traditional Chinese medicine injection].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yan Wang Research Topics

Disease

1469Neoplasms (Cancer)
05/2024 - 01/2002
386Inflammation (Inflammations)
12/2024 - 02/2002
303Neoplasm Metastasis (Metastasis)
05/2024 - 10/2004
298Infections
04/2024 - 12/2002
232Breast Neoplasms (Breast Cancer)
05/2024 - 01/2004
207Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 05/2002
145Lung Neoplasms (Lung Cancer)
04/2024 - 01/2002
145Carcinogenesis
03/2024 - 11/2002
139Fibrosis (Cirrhosis)
05/2024 - 01/2009
136Stomach Neoplasms (Stomach Cancer)
12/2024 - 12/2008
126Hepatocellular Carcinoma (Hepatoma)
05/2024 - 09/2004
124Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 12/2007
110Pain (Aches)
04/2024 - 12/2002
108Hypoxia (Hypoxemia)
05/2024 - 09/2005
103Hypertension (High Blood Pressure)
04/2024 - 02/2004
97Wounds and Injuries (Trauma)
05/2024 - 01/2007
89Type 2 Diabetes Mellitus (MODY)
01/2024 - 07/2003
83Carcinoma (Carcinomatosis)
05/2024 - 01/2005
81Body Weight (Weight, Body)
01/2024 - 02/2006
77Obesity
05/2024 - 08/2008
76Cardiovascular Diseases (Cardiovascular Disease)
05/2024 - 11/2003
76Alzheimer Disease (Alzheimer's Disease)
01/2024 - 10/2004
71Ischemic Stroke
04/2024 - 08/2007
71Glioma (Gliomas)
03/2024 - 06/2006
71Insulin Resistance
03/2024 - 09/2004
71Ovarian Neoplasms (Ovarian Cancer)
02/2024 - 01/2002
70Atherosclerosis
05/2024 - 03/2005
67Melanoma (Melanoma, Malignant)
03/2024 - 07/2005
65Prostatic Neoplasms (Prostate Cancer)
05/2024 - 11/2003
65Adenocarcinoma of Lung
03/2024 - 06/2006
65Stroke (Strokes)
02/2024 - 05/2005
64Myocardial Infarction
04/2024 - 09/2003
62Disease Progression
01/2024 - 08/2006
60Adenocarcinoma
02/2024 - 08/2005
58Hemorrhage
04/2024 - 04/2003
52Esophageal Squamous Cell Carcinoma
03/2024 - 10/2004
51Psoriasis (Pustulosis Palmaris et Plantaris)
05/2024 - 04/2005
51Nasopharyngeal Carcinoma
01/2024 - 11/2004
49Necrosis
04/2024 - 06/2002
49Lymphatic Metastasis
01/2024 - 12/2004
47Sepsis (Septicemia)
05/2024 - 01/2013
47Osteosarcoma (Osteogenic Sarcoma)
12/2023 - 09/2005
47Reperfusion Injury
12/2023 - 12/2002
47Congenital Abnormalities (Deformity)
11/2023 - 01/2006
46COVID-19
05/2024 - 01/2020
44Thrombosis (Thrombus)
04/2024 - 05/2009
43Cognitive Dysfunction
04/2024 - 06/2010
43Ischemia
02/2024 - 02/2004
41Heart Failure
02/2024 - 11/2004
40Virus Diseases (Viral Diseases)
09/2023 - 06/2006
39Asthma (Bronchial Asthma)
03/2024 - 03/2005

Drug/Important Bio-Agent (IBA)

626Proteins (Proteins, Gene)FDA Link
05/2024 - 06/2002
343Biomarkers (Surrogate Marker)IBA
05/2024 - 11/2005
207Messenger RNA (mRNA)IBA
04/2024 - 01/2005
180CytokinesIBA
05/2024 - 04/2006
180MicroRNAs (MicroRNA)IBA
02/2024 - 01/2009
133Therapeutic UsesIBA
04/2024 - 07/2002
131Long Noncoding RNAIBA
04/2024 - 01/2015
126Glucose (Dextrose)FDA LinkGeneric
05/2024 - 01/2003
117DNA (Deoxyribonucleic Acid)IBA
01/2024 - 01/2002
105RNA (Ribonucleic Acid)IBA
04/2024 - 05/2005
103LipidsIBA
05/2024 - 09/2004
98EnzymesIBA
02/2024 - 02/2004
77Interleukin-6 (Interleukin 6)IBA
05/2024 - 11/2008
75Small Interfering RNA (siRNA)IBA
03/2024 - 12/2005
73ErbB Receptors (EGF Receptor)IBA
05/2024 - 10/2006
72Insulin (Novolin)FDA Link
04/2024 - 01/2003
71CateninsIBA
04/2024 - 10/2007
69Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2023 - 09/2005
68Immune Checkpoint InhibitorsIBA
03/2024 - 05/2017
68Cisplatin (Platino)FDA LinkGeneric
01/2024 - 12/2007
67LigandsIBA
05/2024 - 04/2006
63Reactive Oxygen Species (Oxygen Radicals)IBA
03/2024 - 12/2008
62AntioxidantsIBA
12/2024 - 12/2004
62Peptides (Polypeptides)IBA
04/2024 - 03/2008
61Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2024 - 04/2003
58Anti-Bacterial Agents (Antibiotics)IBA
02/2024 - 05/2002
57Tyrosine Kinase InhibitorsIBA
05/2024 - 10/2006
57CholesterolIBA
03/2024 - 07/2002
56Transcription Factors (Transcription Factor)IBA
04/2024 - 08/2006
56Phosphotransferases (Kinase)IBA
03/2024 - 01/2005
55LipopolysaccharidesIBA
03/2024 - 02/2004
55Oxygen (Dioxygen)IBA
03/2024 - 02/2004
53Indicators and Reagents (Reagents)IBA
05/2024 - 10/2009
51Circular RNAIBA
03/2024 - 01/2018
48VaccinesIBA
01/2024 - 10/2005
45CollagenIBA
03/2024 - 12/2007
45Antiviral Agents (Antivirals)IBA
01/2024 - 12/2012
43InflammasomesIBA
03/2024 - 02/2013
41AntigensIBA
12/2023 - 04/2004
40Blood Glucose (Blood Sugar)IBA
01/2024 - 05/2006
39Hormones (Hormone)IBA
04/2024 - 01/2003

Therapy/Procedure

735Therapeutics
12/2024 - 05/2002
305Drug Therapy (Chemotherapy)
04/2024 - 04/2004
117Radiotherapy
03/2024 - 04/2004
110Immunotherapy
04/2024 - 04/2006
65Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2024 - 04/2004
53Osteotomy
01/2024 - 04/2007
48Aftercare (After-Treatment)
04/2024 - 04/2006
47Transplantation
03/2024 - 03/2008